VitaDAO
VC Fund
New York, United States
VitaDAO is a decentralized collective funding early stage longevity research Our mission is to extend human lifespan by researching, financing, and commercializing longevity therapeutics in an open and democratic manner.VitaDAO and its members are committed to nurturing and developing the intellectual property, licenses, and data sets that resultfrom the projects it supports.Members can join VitaDAO by purchasing VITA tokens or earning them through contributions of work or Intellectual Property.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries VitaDAO invests in
Stages VitaDAO invests in
Countries VitaDAO invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 6 contacts → | |||
Investment Focus
Industry
- Biotechnology 2 (100%)
- Genetics 1 (50%)
- InsurTech 1 (50%)
- Health Care 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alex Dobrin
Awareness Steward
|
Awareness Steward | Total investments: 0 | Find email | |
Laurence Ion
Dealflow Steward
|
Dealflow Steward | Total investments: 0 | Find email | |
Matthew ‘Oki’ O’Connor
Senior Reviewer
|
Senior Reviewer | Total investments: 0 | Find email | |
Paul Kohlhaas
Founding Steward
|
Founding Steward | Total investments: 0 | Find email | |
Sebastian Brunemeier
Longevity Working Group
|
Longevity Working Group | Total investments: 3 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ImmuneAGE Bio is an intriguing initiative focused on drug discovery for immune system rejuvenation. Developing therapies that can rejuvenate or enhance the immune system could have profound implications for healthcare, especially in aging populations or those with compromised immune function | $2M / Seed / Jul 11, 2024 | ||
| GERO is an AI Drug Discovery company created to solve chronic diseases. To date, Gero has raised approximately $19 million in total capital through a combination of equity rounds and SAFEs. | $6M / Series A / Oct 18, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does VitaDAO invest in?
VitaDAO invests primarily in Biotechnology, Genetics and InsurTech startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact VitaDAO?
Public channels for VitaDAO include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at VitaDAO?
The team at VitaDAO includes Alex Dobrin (Awareness Steward), Laurence Ion (Dealflow Steward) and Matthew ‘Oki’ O’Connor (Senior Reviewer), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
